Catalent (STU:0C8) Accounts Payable : €347 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Catalent Accounts Payable?

Catalent's Accounts Payable for the quarter that ended in Mar. 2024 was €347 Mil.

Catalent's quarterly Accounts Payable increased from Sep. 2023 (€344 Mil) to Dec. 2023 (€373 Mil) but then declined from Dec. 2023 (€373 Mil) to Mar. 2024 (€347 Mil).

Catalent's annual Accounts Payable increased from Jun. 2021 (€320 Mil) to Jun. 2022 (€398 Mil) but then declined from Jun. 2022 (€398 Mil) to Jun. 2023 (€391 Mil).

Catalent Accounts Payable Historical Data

The historical data trend for Catalent's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Catalent Accounts Payable Chart

Catalent Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Accounts Payable

Get a 7-Day Free Trial

226.38

285.05

319.55

398.27

391.35

Catalent Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable	Get a 7-Day Free Trial															368.00	391.35	343.88	373.22	346.84

Catalent Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Catalent Accounts Payable Related Terms

Thank you for viewing the detailed overview of Catalent's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Catalent (STU:0C8) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Catalent Inc (STU:0C8) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

CTLT:USA

Address

14 Schoolhouse Road, Somerset, NJ, USA, 08873

Website

https://www.catalent.com

Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents.

Catalent (STU:0C8) Headlines

No Headlines